Search Weight Loss Topics:

Page 517«..1020..516517518519..530540..»

Keto diet could reduce the risk of Alzheimer’s disease – India New England

Posted: September 21, 2020 at 3:54 pm

Hyderabad Eating healthy, low calorie food could help fight the fungi in the gut and thus reduce the risk of dementia among senior citizens, doctors said, citing a new study done in the US that revealed that the diet has a direct connection with Alzheimers disease.

The findings of the recent study by scientists at the Wake Forest School of Medicine are significant as health experts are looking at possible therapies to address the grave problem.

The Alzheimers Association, a global body for dementia, reported that mild cognitive impairment (MCI) is witnessed among at least 15-20 per cent people aged over 65 years, which impacts the ability to think and can lead to Alzheimers disease.

The new research suggests that ketogenic diet alters the bacterial communities in the human gut and helps reduce biomarkers of Alzheimers disease among those suffering from MCI.

In our conservative society, dementia often impacts social and family relations, including reduction in work hours, loss of employment, relationships ending, and even the need to relocate or change living arrangements arises. It is often noticed that such problems lead victims to becoming unwanted in the family and social setting. Possible solutions to prevent this problem are being researched for decades, and this new study provides a glimpse of hope, said Dr Simanchal Mishra, Senior Consultant Neuro Physician, Medicover Hospitals.

There is now a possible preventive mechanism through which the risk of Alzheimers can be reduced to a great extent, and the suggested solution appears to be an easily manageable one, he added.

Alzheimers is an irreversible dementia. There are many other causes of dementia which are preventable or reversible. Early diagnosis and treatment of dementia can help make the disease reversible. Literacy/ knowledge of the ailment is one of the most important factors in preventing Alzheimers disease, said Dr M.K. Singh, Senior Consultant Neurologist, Continental Hospitals.

While quitting smoking and alcohol, eating healthy diet, exercising for at least 150 minutes a week are suggested as steps to prevent Alzheimers disease, the new research reveals that lower calories food forces a human body to conserve energy, and this leads to drop in body temperature, and this too helps in preventing dementia. Additionally, reading, writing, learning new languages and/or musical instruments, maintaining an active social life are highly recommended to ensure Alzheimers is kept at bay, he said.

Conditions like high blood pressure, high cholesterol, and diabetes, which are known to increase the risk of cardiovascular diseases, also increase the risk of developing Alzheimers among ageing population. Hence, in addition to leading an active life, cutting down on calories in food is surely a great way to stay happy and remember everything till the end of life. (IANS)

See the rest here:
Keto diet could reduce the risk of Alzheimer's disease - India New England

COVID-19 Update: Global Ayurvedic Diet and Medicines Market is Expected to Grow at a Healthy CAGR with Top players: Botique, Herbal Hills, Basic…

Posted: September 21, 2020 at 3:54 pm

Global Ayurvedic Diet and Medicines Market 2020 research report presents analysis of market size, share, and growth, trends, cost structure, statistical and comprehensive data of the global market. Research reports analyses the major opportunities, CAGR, yearly growth rates to help the readers to understand the qualitative and quantitative aspects of theGlobal Ayurvedic Diet and MedicinesMarket. The competition landscape, company overview, financials, recent developments and long-term investments related to theGlobal Ayurvedic Diet and Medicines Marketare mentioned in this report.

The key segments covered in this report are geographical segments, end-use/application segments, and competitor segments. The local segment, regional supply, application, and wise demand, major players, prices are also available by 2025. Global Ayurvedic Diet and Medicines Market are mentioned in the competition landscape, company overview, financials, recent developments and long-term investments.

Get PDF Sample Copy of the Report (Including Full TOC, List of Tables & Figures, Chart):https://www.marketinforeports.com/Market-Reports/Request-Sample/155146

Top Key players profiled in the Ayurvedic Diet and Medicines market report include:Botique, Herbal Hills, Basic Ayurveda, Natreon, Emami Group, Dabur, Baidyanalh, Shahnaz Husain Group, Himalaya Drug, Ke and More

Market segmentation, by product types:DietMedicinesMarket segmentation, by applications:WomenMen

global Ayurvedic Diet and Medicines market report also highlights key insights on the factors that drive the growth of the market as well as key challenges that are required to Ayurvedic Diet and Medicines market growth in the projection period. Here provide the perspectives for the impact of COVID-19 from the long and short term. Ayurvedic Diet and Medicines market contain the influence of the crisis on the industry chain, especially for marketing channels. Update the industry economic revitalization plan of the country-wise government.

To Understand the influence of COVID-19 on the Set Screw Market with our analysts monitoring the situation across the globe. Get here sample analysis

Other Important Key Points of Ayurvedic Diet and Medicines Market:

Years considered for this report:

Key questions answered in this report:

To get Incredible Discounts on this Premium Report, Click Here @ https://www.marketinforeports.com/Market-Reports/Request_discount/155146

Key point summary of the Global Ayurvedic Diet and Medicines Market report:

Detailed TOC of Ayurvedic Diet and Medicines Market Report 2020-2025:

Chapter 1 Ayurvedic Diet and Medicines Market Overview

Chapter 2 Economic Impact on Industry

Chapter 3 Market Competition by Manufacturers

Chapter 4 Production, Revenue (Value) by Region

Chapter 5 Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Production, Revenue (Value), Price Trend by Type

Chapter 7 Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Ayurvedic Diet and Medicines Market Forecast

Continued

For More Information with full TOC: https://www.marketinforeports.com/Market-Reports/155146/Ayurvedic-Diet-and-Medicines-market

Customization of the Report:Market Info Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Get Customization of the [emailprotected]:https://www.marketinforeports.com/Market-Reports/Request-Customization/155146/Ayurvedic-Diet-and-Medicines-market

Get in Touch with Us :Mr. Marcus KelCall: +1 915 229 3004 (U.S)+44 7452 242832 (U.K)Email: s[emailprotected]Website: http://www.marketinforeports.com

View original post here:
COVID-19 Update: Global Ayurvedic Diet and Medicines Market is Expected to Grow at a Healthy CAGR with Top players: Botique, Herbal Hills, Basic...

A Bipartisan Bill Would Regulate Hemp CBD As A Dietary Supplement – The Fresh Toast

Posted: September 21, 2020 at 3:54 pm

Last week, Oregon Representative Kurt Schrader (D) and Virginia Representative Morgan Griffith (R) introducedThe Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020(H.R. 8179). If enacted in its current form, H.R. 8179 would legalize the manufacture, sale and marketing of hemp, hemp-derived cannabidiol and other hemp extracts (collectively referred to as Hemp Products) as dietary supplements under the Federal Food, Drug and Cosmetic Act (FDCA).

This means that these products would be exempt from the FDCAs Drug Exclusion Rule, which, as we previously discussed, currently prevents the sale and marketing of any substance that has been approved or investigated by the FDA as a new drug as a conventional food or dietary supplement In July 2018, the FDA approved CBD as a drug ingredient inEpidiolex.

To be compliant with the FDCA, these Hemp Products would need to meet the existing regulatory framework imposed on dietary supplements. This comprehensive regulatory framework mandates, in part, that these products be safe as well as properly labeled and marketed.

Because Hemp Products were not sold and marketed in the U.S. as dietary supplements or conventional foods before October 15, 1994, they would be deemed new dietary ingredients or NDIs.

Pursuant to Section 413 of the FDCA, if a dietary supplement contains an NDI, its manufacturer and distributor must ensure that the NDI is adequately substantiated as being safe and must notify the FDA about that ingredientpriorto marketing.

RELATED: FDA Guidance On Cannabis Research: A Glimpse Of Whats To Come For CBD Products?

To meet this standard, manufacturers and distributor of Hemp Products would have to provide the FDA with information that is the basis on which they have concluded that their Hemp Products are reasonably expected to be safe under the conditions recommended or suggested in the labeling.

Photo by athima tongloom/Getty Images

If the manufacturers or distributors were to receive a no-objection letter from the FDA, or no response at all, they could lawfully market their Hemp Products after the 75-day notification period is over, assuming there is in fact a history of use or other evidence of safety establishing that the Hemp Products, when used under the conditions recommended or suggested in the labeling, are reasonably expected to be safe.

When it comes to labeling requirements, manufacturers and distributors of Hemp Products would need to ensure their product packaging contains specificlabeling elements, such as an identity statement and a nutrition facts panel and containno medical claimsabout the therapeutic values of their products. Inclusion of medical claims would suggest that the Hemp Products intended use is that of a drug, and thus, would violate the FDCA and warrantFDA and Federal Trade Commission(FTC) enforcement actions.

RELATED: DEA Interim Final Rule: What Is Synthetically Derived THC?

In sum, the enactment of H.R. 8179 would help alleviate regulatory uncertainties surrounding the legality of Hemp Products, which have hindered market opportunities for hemp farmers and businesses. In addition, the passage of this bipartisan bill would help raise the quality and safety of Hemp Products, and thus, protect consumers.

If, like aconsensusof hemp stakeholders, you support H.R. 8129, you should contact your representatives and urge them to co-sponsor this bill. For automatically generated messages, visit the U.S. Hemp Rountables onlineAction Center.

Nathalie Bougeniesis an attorney atHarris Bricken. This article wasoriginally published on theCanna Law Blog and is reposted with permission.

More:
A Bipartisan Bill Would Regulate Hemp CBD As A Dietary Supplement - The Fresh Toast

Keto Diet Market| Insights on the Crisis and the Roadmap to Recovery from COVID-19 Pandemic| Technavio – Yahoo Finance

Posted: September 21, 2020 at 3:54 pm

TipRanks

Is more volatility on tap for stocks? Following a three-week losing streak, the longest in about a year, all eyes are on the market. The three major U.S. stock indexes have struggled for the last few weeks as the titans of tech, which have fueled the charge forward from COVID-induced lows, came under pressure due to overheated valuations, with market watchers waiting to see how renewed lockdown fears will come into play.So, whats the bottom line for investors? Even though uncertainty remains as Wall Street gears up for the fourth quarter, the pros are pounding the table on a select few names, noting that these tickers boast strong long-term growth narratives.Bearing this in mind, our focus shifted to two penny stocks backed by investment firm Cantor. Major gains could be in store, as the firms analysts believe these tickers trading for less than $5 per share could climb all the way to $11.These plays are known for being risky, so we turned to TipRanks database. Using the platform, we got the full scoop, to find out why both are so compelling even with the risk involved.Rockwell Medical (RMTI)With the goal of transforming iron deficiency and anemia management in a wide variety of therapeutic areas, Rockwell Medical works to improve the lives of patients all over the world. Given the strength of its technology and its $1.22 share price, Cantor thinks that now is the time to snap up shares.Firm analyst Brandon Folkes notes that RMTI has begun to build on its presence in the dialysis market with the recent launch of dialysate Triferic, which is the first and only FDA-approved treatment for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease. This formulation is administered through the dialysate (mixed with liquid bicarbonate).On top of this, an IV formulation of Triferic (Triferic Avnu) will enter clinical evaluation in Q3 2020, with Folkes expecting the commercial release to come in the following quarter. Folkes said, The company continues to believe in the future of Triferic, dialysate and IV formulations, and is executing on its commercial strategy, which takes time to get adoption. Speaking to this commercial strategy, RMTI is offering three-month evaluation periods for Triferic and has converted 75% of clinics who completed the evaluation period. RMTI is also positioning Triferic at a price that results in a cost neutral position for the clinics, while receiving the clinical benefits from Triferic.Additionally, the company is set to hold a virtual investor meeting this month to discuss the opportunity for two new indications, total parental nutrition (TPN) and hospitalized acute decompensated congestive heart failure (CHF)....we believe this incremental information is a meaningful positive, as while RMTI had previously noted its indication in exploring additional indications, investors will now have a concrete map of the development work the company will employ to fully maximize the platform within a product potential of the Triferic platform, Folkes stated.If that wasnt enough, on September 9, RMTI announced that it has entered into an exclusive license agreement with Jeil Pharmaceutical for the rights to commercialize Triferic in South Korea. As per the terms of the agreement, RMTI will receive an upfront fee and is eligible for milestone payments and royalties on net sales.All of the above prompted Folkes to comment, We believe Triferic is an innovative product that will drive significant value for RMTI shareholders. We expect product approvals and upward earnings revisions in our DCF model to drive RMTI's stock higher.To this end, Folkes rates RMTI an Overweight (i.e. Buy) along with an $11 price target. Should the target be met, a twelve-month gain in the shape of a whopping 801% could be in store. (To watch Folkes track record, click here)Turning now to the rest of the Street, 2 Buys and no Holds or Sells have been published in the last three months. Therefore, RMTI has a Moderate Buy consensus rating. Based on the $10 average price target, shares could soar 719% in the next year. (See RMTI stock analysis on TipRanks)Taiwan Liposome Company (TLC)Using its LipAD lipid-assembled delivery system to enable sustained release and targeted deliveries that reduce toxicity and improve efficacy, Taiwan Liposome Company develops cutting-edge nanomedicines. Currently going for $4.38 apiece, Cantor views TLC as an under-the-radar story and believes its share price reflects an attractive entry point.Writing for the firm, analyst Kristen Kluska told clients, TLC is underappreciated considering the management has an extensive track record in liposomal products (including two acquisitions). She cites the company's two late-stage development programs, TLC599 (its BioSeizer formulation of dexamethasone sodium phosphate (DSP) designed to provide relief for knee osteoarthritis (OA) pain) and TLC590 (its therapy for post-surgical pain), that could present with advantages over current standard of care extended release products, in large markets.According to Kluska, the company remains on track to complete enrollment for the Phase 3 study of TLC599 by YE20. Further, TLC believes this program is superior to the competition as its possible to receive one injection every six months and show that repeated dosing is both safe and effective.Kluska added, Further, TLC599 consists of just one vial, which could allow for a quick preparation, whereas Zilretta has two vials, thus a potentially longer preparation time. The company also has flexibility with the needle size that could be used for this product, and believes there could be a potential utilization in the joints, hip, shoulder, etc., which the company could consider evaluating in the future. To this end, should the results be positive, the company could submit an NDA during 1H22.When it comes to TLC590, TLC already reported topline results from the Phase 2 post-surgical pain following bunionectomy study earlier this summer, arguing the candidate has a faster onset and a longer duration than other therapies. Now, management needs to meet with the FDA to discuss pivotal trial designs. As a reminder, TLC is evaluating a different API (ropivacaine) vs. competitors, which could potentially show a stronger safety profile. The company also believes this product could have lower COGS, which could allow for attracting pricing, Kluska pointed out.If that wasnt enough, TLC recently revealed it is evaluating a NanoX sustained release of hydroxychloroquine (HCQ) inhalation for prophylaxis and treatment of COVID-19. It already submitted an IND, and could be ready to initiate a Phase 1 study after approval, with data potentially coming by early 2021. It should be noted that Taiwan is the second largest API producer for HCQ in the world, so the company has clear access, in Kluskas opinion.It should come as no surprise, then, that Kluska stays with the bulls. The analyst rates TLC an Overweight (i.e. Buy) along with an $11 price target. Should her thesis play out, a potential twelve-month gain of 154% could be in the cards. (To watch Kluskas track record, click here)What does the rest of the Street have to say? With 2 Buys and zero Holds or Sells, the word on the Street is that TLC is a Moderate Buy. In addition, the $11 average price target matches Kluskas. (See TLC stock analysis on TipRanks)To find good ideas for penny stocks trading at attractive valuations, visit TipRanks Best Stocks to Buy, a newly launched tool that unites all of TipRanks equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Original post:
Keto Diet Market| Insights on the Crisis and the Roadmap to Recovery from COVID-19 Pandemic| Technavio - Yahoo Finance

Global Testosterone Replacement Therapy Market 2020 Trends Analysis and Coronavirus (COVID-19) Effect Analysis | Key Players Market With COVID-19…

Posted: September 21, 2020 at 3:52 pm

Global Testosterone Replacement Therapy Market 2020: Business Growth Rate, Manufacturing Analysis, Size, Share, Cost Structure, and Forecast to 2026

The Market Data Analytics published a recent report on the globalTestosterone Replacement Therapy market, which was studied by the research analysts for months. The report includes information from trusted primary and secondary resources along with detailed examination from the research analysts. Based on the analysis, research analysts have concluded that the global demand for the global Testosterone Replacement Therapy market was USD XX Million in 2019 and is anticipated to reach USD XX Million by the end of 2026. The expected CAGR for the market is around XX%.

Ask for a Sample Copy of the Report (Use Corporate email ID to Get Higher Priority):https://www.marketdataanalytics.biz/global-testosterone-replacement-therapy-market-20202027-by-player-41201.html#request-sample

Final Report will add the analysis of the impact of COVID-19 on this Industry.

The other factors that the report delivers is the revenue estimations, sales volume, industry size, and other important aspects, which includes market segmentation, growth factors, restraints, opportunities, challenges, and the market players.

The global Testosterone Replacement Therapy market incorporates information such as the basic overview of the industry, which includes definition, segmentation, and the industry structure. The global Testosterone Replacement Therapy market is segmented on the basis of{Gels, Injections, Patches, Other}; {Hospitals, Clinics, Others}. Along with this the product types and the applications of the Testosterone Replacement Therapy market are also discussed. Other data that is provided includes developmental trends, regional analysis of the Testosterone Replacement Therapy market, and the technological advancements. The developmental policies that have been updated are all discussed in the report.

Browse Full Report with More Professional and Technical Insights Including COVID-19 Impact@https://www.marketdataanalytics.biz/global-testosterone-replacement-therapy-market-20202027-by-player-41201.html

Some of the top most key players that are enlisted in the report areAbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals. The details that are represented in the report includes the cost structures, manufacturing process methodology, import and export consumption, supply and demand patterns, gross margins, recent developments made in the business, revenue analysis, and gross margins.

The report offers a comprehensive understanding of market dynamics across key regions, namely North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), Latin America (Brazil, Argentina), and the Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa).

Contact Us For More Inquiry of Testosterone Replacement Therapy Report at::https://www.marketdataanalytics.biz/global-testosterone-replacement-therapy-market-20202027-by-player-41201.html#inquiry-for-buying

Key Questions Answered In The Report:

What is the growth potential of the global Testosterone Replacement Therapy market? Which regional market will emerge as a frontrunner during the forecast period 2020-2026? Which application segment will grow at a robust rate? What are the growth opportunities that may emerge in the industry in the years to come? What are the key challenges that the global market may face in the future? Which are the main companies in the global Testosterone Replacement Therapy market? Which are the growth strategies considered by the players to sustain hold in the global market?

Why Go For Market Data Analytics Research?

Market Data Analytics is a leading global market research and consulting firm. We focus on business consulting, industrial chain research, and consumer research to help customers provide non-linear revenue models. We believe that quality is the soul of the business and that is why we always strive for high quality products. Over the years, with our efforts and support from customers, we have collected inventive design methods in various high-quality market research and research teams with extensive experience.

See the original post:
Global Testosterone Replacement Therapy Market 2020 Trends Analysis and Coronavirus (COVID-19) Effect Analysis | Key Players Market With COVID-19...

Testosterone Replacement Therapy Market Growth Analysis with Top Players Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International…

Posted: September 21, 2020 at 3:52 pm

GlobalTestosterone Replacement Therapy MarketResearch Report is a resource, which provides current as well as upcoming technical and financial details of the industry to 2027. This report gives you so important and essentials data of Market size, share, trends, Growth, applications, forecast and cost analysis. Delivery development in North America, China, Europe, and South East Asia, Japan as well as in the Globe. The report proves to be indispensable when it comes to market definition, classifications, applications and engagements.

The market report also computes the market size and revenue generated from the sales. The industry analysis report presents the key statistics on the market status of global and regional manufacturers and also acts as a valuable source of leadership and direction. What is more, the Testosterone Replacement Therapy market report analyses and provides historic data along with the current performance of the market.

Get a Free Sample Copy of the Testosterone Replacement Therapy Market Report with Latest Industry Trends @https://www.coherentmarketinsights.com/insight/request-sample/2024

Global Testosterone Replacement Therapy Market competition by Top Key Players: AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Testosterone Replacement Therapy Market section by Region:

Segmentation: The report has been separated into different categories, such as product type, application, end user, and region. Every segment is evaluated based on the CAGR, share and growth potential. In the regional analysis, the report highlights the prospective region, which should generate opportunities in the global Testosterone Replacement Therapy market in the years to come. This segmented analysis will surely prove to be a useful tool for readers, stakeholders and market participants to get a full picture of the Testosterone Replacement Therapy global market and its growth potential in the years to come.

The Testosterone Replacement Therapy Market report offers a plethora of insights which include:

Changing consumption patterns among individuals globally.

Historical and future progress of the global Testosterone Replacement Therapy market.

Region-wise and country-wise segmentation of the Testosterone Replacement Therapy market to understand the revenue, and growth lookout in these areas.

Accurate Year-on-Year growth of the global Testosterone Replacement Therapy market.

Important trends, including proprietary technologies, ecological conservation, and globalization affecting the global Testosterone Replacement Therapy market.

Need a discount?

Note: *The discount is offered on the Standard Price of the report.

To get Incredible Discounts on this Premium Report, Click Here @https://www.coherentmarketinsights.com/insight/request-discount/2024

Important Information that can be extracted from the Report:

Assessment of the COVID-19 impact on the growth of the Testosterone Replacement Therapy Market

Successful market entry strategies formulated by emerging market players

Pricing and marketing strategies adopted by established market players

Country-wise assessment of the Testosterone Replacement Therapy Market in key regions

Year-on-Year growth of each market segment over the forecast period 2026

The Testosterone Replacement Therapy Market report considers the following years to predict market growth:

Historic Year: 2014 2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2020 2027

The Global Testosterone Replacement Therapy Market is displayed in 13 Chapters:

Chapter 1: Market Overview, Drivers, Restraints and Opportunities

Chapter 2: Market Competition by Manufacturers

Chapter 3: Production by Regions

Chapter 4: Consumption by Regions

Chapter 5: Production, By Types, Revenue and Market share by Types

Chapter 6: Consumption, By Applications, Market share (%) and Growth Rate by Applications

Chapter 7: Complete profiling and analysis of Manufacturers

Chapter 8: Manufacturing cost analysis, Raw materials analysis, Region-wise manufacturing expenses

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Market Effect Factors Analysis

Chapter 12: Market Forecast

Chapter 13: Testosterone Replacement Therapy Research Findings and Conclusion, Appendix, methodology and data source

Have Any Query? Ask Our Expert @ https://www.coherentmarketinsights.com/insight/request-customization/2024

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia or Oceania [Australia and New Zealand].

Contacts Us:

Mr. ShahCoherent Market Insights,1001 4th Ave,#3200 Seattle, WA 98154, U.S.Email:[emailprotected]Phone: US +1-206-701-6702/UK +44-020 8133 4027

See more here:
Testosterone Replacement Therapy Market Growth Analysis with Top Players Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International...

Testosterone boosters: Uses and effectiveness – Medical News Today

Posted: September 21, 2020 at 3:52 pm

Testosterone boosters include medications and supplements designed to increase testosterone levels in the body. While low testosterone can trigger a range of symptoms, increasing this hormone comes with risks.

In this article, we discuss different types of testosterone boosters and their effectiveness.

Testosterone is an androgen hormone that promotes the development of characteristics people typically associate with masculinity, such as facial hair, deep voice, and muscle growth.

Although testosterone is the principal male sex hormone, it is also present in females, though at much lower levels.

Testosterone influences various aspects of the human body, including:

The normal testosterone value in people varies due to many factors, such as age. The American Urological Association defines low testosterone as less than 300 nanograms per deciliter (ng/dL).

A 2017 study suggests the normal total testosterone range for males aged 1939 years is 264916 ng/dL. The research considers values higher than this as abnormally high.

Low testosterone, or hypogonadism, can occur due to an underlying medical condition, taking certain medications, or injuries to the testes. People may also experience high testosterone levels, typically due to anabolic steroid use, tumors on the adrenal glands, or a medical condition.

A testosterone booster, or testosterone supplement, refers to any natural or artificially produced substance that raises testosterone levels. These may include:

TRT, or androgen replacement therapy, is a medical treatment for low testosterone. It works by replacing the testosterone that the body is not producing. TRT may include:

Injectable testosterone, such as testosterone cypionate (Depo-Testosterone) and testosterone undecanoate (Aveed), contain testosterone esters suspended in oil. Esters are a type of biological compound.

A person can administer this form of testosterone by injecting the solution into the buttocks. People can take these injections every 24 weeks, depending on recommendations from doctors.

Transdermal testosterone includes medicated patches (Androderm) and gels (AndroGel) that people apply directly to the skin.

Androderm patches come in four different strengths: 2 mg, 2.5 mg, 4 mg, or 5 mg of testosterone. The recommended starting dose is one 4 mg patch every 24 hours. A person should apply this to clean, dry skin on the back, thighs, abdomen, or upper arms.

Testosterone gel is available at 1% and 1.62% concentrations. When starting the 1% formulation, a person should apply 50 mg once a day in the morning. The dosage can vary depending on their hormone levels.

Jatenzo is an oral testosterone capsule recently approved by the Food and Drug Administration (FDA) for treating hypogonadism due to underlying medical conditions. The FDA does not recommend Jatenzo for treating age-related low testosterone due to an increased risk of cardiovascular events.

Jatenzo is available in three strengths: 158 mg, 198 mg, and 237 mg. The manufacturers recommend that people start by taking 237 mg twice daily for 1 week. In clinical trials, 87% of participants achieved testosterone levels in the normal range at the end of treatment.

After the first week, a doctor can adjust the dosage according to a persons serum testosterone levels. People should also note that due to a potential increase in blood pressure, Jatenzo may increase the risk of cardiovascular events.

Some supplements may help increase the level of testosterone a persons body produces. These may include:

D-aspartic acid (DAA) is an amino acid that plays a role in creating and releasing several different hormones, including testosterone.

DAA acts on the hypothalamus, triggering an increase of gonadotropin-releasing hormone (GnRH). When GnRH is present, the pituitary gland releases luteinizing hormone (LH), which promotes testosterone production.

Dehydroepiandrosterone (DHEA) is a steroid hormone produced by the adrenal glands. It is a precursor hormone with minimal effects until the body converts it into other hormones, such as estrogen or testosterone.

Due to its effects, DHEA is a popular ingredient in testosterone-boosting supplements.

There are several reasons why a person might use testosterone boosters. These include:

Multiple factors can influence testosterone levels. The body naturally produces less of the hormone with age. In one 2016 study, researchers evaluated the levels of testosterone and DHEA of 271 healthy males between the ages of 4070.

The researchers found testosterone levels decreased by 1.28%, and DHEA decreased by 3.52% each year.

The following factors can lead to low testosterone levels:

TRT is effective in treating low testosterone, but it does not always address the underlying cause. A doctor may recommend lifestyle changes and other medication to treat hypogonadism due to overweight, metabolic disorders, or thyroid problems.

In a 2018 study, researchers coordinated seven controlled trials in 788 older males with low testosterone levels. The participants received either AndroGel 1% or a placebo for 12 months.

The results suggest that testosterone treatment led to moderate improvements in sexual function, bone density, and red blood cell count. Those in the testosterone treatment group showed mild improvements in walking distance, mood, and depressive symptoms.

In a 2017 article, researchers evaluated the efficacy of d-aspartic acid (DAA) reported in 27 animal and human studies.

Findings from the animal studies suggest that DAA increases testosterone levels. However, the human trials produced mixed results. This may be due to limitations of the study design, as well as differences in age, physical fitness levels, and the participants base testosterone levels.

A 2015 study researching the effects of DAA supplementation in 24 males with at least two years of resistance training suggests this technique either showed no significant changes or reduced testosterone levels based on the dosage.

The authors of a 2013 review examined findings from 25 randomized controlled trials that looked at the effects of DHEA supplementation in 1,353 men. The authors conclude it led to minor reductions in body fat, but no improvements in testosterone.

A 2018 review also states there is limited evidence to suggest that DHEA supplementation increases testosterone levels.

Testosterone boosters may provide the following benefits to people with low testosterone levels:

While testosterone replacement may help alleviate the symptoms of hypogonadism, it may not produce the same effects in people with naturally declining testosterone levels.

TRT may lead to the following side effects:

People who inject testosterone may experience pain, swelling, or bruising near the injection site. Topical testosterone gels and patches can also induce allergic reactions at the application site.

The American Urological Association only recommend TRT if a persons testosterone level is below 300 ng/dL, and they show symptoms of hypogonadism. However, the risks of TRT may outweigh its potential benefits.

The FDA does not regulate testosterone supplements, meaning that supplements vary widely in quality, purity, and dosage.

According to the FDA, there is a link between some bodybuilding supplements, as well as products marketed as testosterone alternatives, and the following adverse effects:

Testosterone boosters can help increase a persons testosterone levels. However, their effectiveness will vary based on the type of booster and a persons reasons for taking them.

Testosterone therapy appears to benefit people with conditions such as hypogonadism. However, TRT is usually not recommended to treat age-related declines in testosterone unless managing sexual dysfunction.

More research is necessary to support the use of alternative therapies, such as testosterone supplements. Supplements may also carry some risk of cardiovascular, kidney, and liver disease.

People should always consult a doctor before they start a new medication or supplement.

See more here:
Testosterone boosters: Uses and effectiveness - Medical News Today

‘I Didn’t Have To Work Out Every Day To Lose Weight When I Finally Stopped Having Cheat Meals’ – msnNOW

Posted: September 20, 2020 at 10:58 am

Courtesy Shavonda Brickley started eating a keto diet, practicing 16:8 intermittent fasting, working with a personal trainer, and cut out cheat meals to lose 143 lbs.

My name is Shavonda Brickley (@shrinking_shavonda), and I am 35 years old. I live in Dallas, Texas, and I am a customer service representative for a pharmaceutical company. I started my weight-loss journey by doing keto with intermittent fasting and working out with a personal trainer, and I lost 143 pounds.

I tried so many different weight-loss methods and did not stick to any of them. The thing I struggled with the most was consistency. I was my heaviest at 28 years old; I weighed 347 pounds.

In December 2017, I went through a life-altering event that put me in a really dark place. I was giving so much energy to that situation. In addition, I always felt like everyone elses happiness was more important than mine. I was always placing myself on the back burner. I felt that it was time for all of that stop. If I could pour so much into others (and wanted to continue to be able to do that), I needed to first pour into me.

And thats when things clicked. Before I could be the best mom or partner to anyone, I needed to be the best me to me.

Initially, I just tried to eliminate things like soda and juice from my diet. I made small adjustments like going from white rice to brown and eating more fruits and salad.

Then I came across the ketogenic lifestyle via Instagram and slowly transitioned into it. I would order a burger and remove one bun, and sub out fries for fruit. Eventually, I did more research and learned more about the lifestyle and went full-blown keto in July 2019. I love how non-restrictive keto is. I can still eat all of the foods I love, and there are so many products that can be used as great substitutes for some of the things that are not allowed.

Shortly after that, I also started to incorporate intermittent fasting (IF) by following a 16:8 schedule (meaning I ate within an eight-hour window every day and fasted for 16 hours).

I would work out six to seven days a week and eat properly during the week, but I would overindulge on the weekends. I thought of cheat meals as a way to reward myself, not realizing initially that this mindset was stalling my progress.

Currently, I have a personal trainer that I see at least three times per week. When I am not training with him, I may walk about four miles or do my C25K running app. I absolutely love working with my trainer. Before COVID-19, I would attend my favorite cardio hip-hop class called Mixxedfit at my local gym. I miss that class so much!

These three changes have made the biggest impact on my overall weight loss.

My advice to anyone who feels stuck or unsure of how to start: It doesnt matter where you start or how much weight you have to lose, just start! Dont focus on how long it will take, just focus on the direction in which youre going. Do not compare your journey to anyone elses.

Keep your head in the game and love yourself enough to get started. Be kind to yourself during your journey. Focus on the progression and not perfection. This journey is yours. Embrace it and take it on full-speed. Dont give upyou have nothing to lose but weight.

Try 200+ at home workout videos from Mens Health, Womens Health, Prevention, and more on All Out Studio free for 14 days!

Gallery: I Stopped Eating Oil For 6 Weeks, and My Skin, Energy, and Digestion Have All Improved (PopSugar)

Original post:
'I Didn't Have To Work Out Every Day To Lose Weight When I Finally Stopped Having Cheat Meals' - msnNOW

Good nutrition can contribute to keeping COVID-19 and other diseases away – The Conversation US

Posted: September 20, 2020 at 10:58 am

The connection between the pandemic and our dietary habits is undeniable. The stress of isolation coupled with a struggling economy has caused many of us to seek comfort with our old friends: Big Mac, Tom Collins, Ben and Jerry. But overindulging in this kind of food and drink might not just be affecting your waistline, but could potentially put you at greater risk of illness by hindering your immune system.

Hear the word nutrition, and often what comes to mind are fad diets, juice cleanses and supplements. Americans certainly seem concerned with their weight; 45 million of us spend US$33 billion annually on weight loss products. But one in five Americans consumes nearly no vegetables less than one serving per day.

When the emphasis is on weight loss products, and not healthy day-to-day eating, the essential role that nutrition plays in keeping us well never gets communicated. Among the many things I teach students in my nutritional biochemistry course is the clear relationship between a balanced diet and a strong, well-regulated immune system.

Along with social distancing measures and effective vaccines, a healthy immune system is our best defense against coronavirus infection. To keep it that way, proper nutrition is an absolute must. Although not a replacement for medicine, good nutrition can work synergistically with medicine to improve vaccine effectiveness, reduce the prevalence of chronic disease and lower the burden on the health care system.

Scientists know that people with preexisting health conditions are at greater risk for severe COVID-19 infections. That includes those with diabetes, obesity, and kidney, lung or cardiovascular disease. Many of these conditions are linked to a dysfunctional immune system.

Patients with cardiovascular or metabolic disease have a delayed immune response, giving viral invaders a head start. When that happens, the body reacts with a more intense inflammatory response, and healthy tissues are damaged along with the virus. Its not yet clear how much this damage factors into the increased mortality rate, but it is a factor.

What does this have to do with nutrition? The Western diet typically has a high proportion of red meat, saturated fat and whats known as bliss point foods rich in sugar and salt. Adequate fruit and vegetable consumption is missing. Despite the abundance of calories that often accompanies the Western diet, many Americans dont consume nearly enough of the essential nutrients our bodies need to function properly, including vitamins A, C and D, and the minerals iron and potassium. And that, at least in part, causes a dysfunctional immune system: too few vitamins and minerals, and too many empty calories.

A healthy immune system responds quickly to limit or prevent infection, but it also promptly turns down the dial to avoid damaging the cells of the body. Sugar disrupts this balance. A high proportion of refined sugar in the diet can cause chronic, low-grade inflammation in addition to diabetes and obesity. Essentially, that dial is never turned all the way off.

While inflammation is a natural part of the immune response, it can be harmful when its constantly active. Indeed, obesity is itself characterized by chronic, low-grade inflammation and a dysregulated immune response.

And research showsthat vaccines may be less effective in obese people. The same applies to those who regularly drink too much alcohol.

Nutrients, essential substances that help us grow properly and remain healthy, help maintain the immune system. In contrast to the delayed responses associated with malnutrition, vitamin A fights against multiple infectious diseases, including measles. Along with vitamin D, it regulates the immune system and helps to prevent its overactivation. Vitamin C, an antioxidant, protects us from the injury caused by free radicals.

Polyphenols, a wide-ranging group of molecules found in all plants, also have anti-inflammatory properties. Theres plenty of evidence to show a diet rich in plant polyphenols can lower the risk of chronic conditions, like hypertension, insulin insensitivity and cardiovascular disease.

Why dont we Americans eat more of these plant-based foods and fewer of the bliss-based foods? Its complicated. People are swayed by advertising and influenced by hectic schedules. One starting place would be to teach people how to eat better from an early age. Nutrition education should be emphasized, from kindergarten through high school to medical schools.

Millions of Americans live in food deserts, having limited access to healthy foods. In these circumstances, education must be paired with increased access. These long-term goals could bring profound returns with a relatively small investment.

[Deep knowledge, daily. Sign up for The Conversations newsletter.]

Meantime, all of us can take small steps to incrementally improve our own dietary habits. Im not suggesting we stop eating cake, french fries and soda completely. But we as a society have yet to realize the food that actually makes us feel good and healthy is not comfort food.

The COVID-19 pandemic wont be the last we face, so its vital that we use every preventive tool we as a society have. Think of good nutrition as a seat belt for your health; it doesnt guarantee you wont get sick, but it helps to ensure the best outcomes.

The rest is here:
Good nutrition can contribute to keeping COVID-19 and other diseases away - The Conversation US

Testosterone Replacement Therapy Market to Witness Exponential Growth by 2020-2027 | Leading Players AbbVie, Endo International, Eli lilly, Pfizer,…

Posted: September 20, 2020 at 10:58 am

Fort Collins, Colorado The report on the Testosterone Replacement Therapy Market provides an in-depth assessment of the Testosterone Replacement Therapy market including technological advancements, market drivers, challenges, current and emerging trends, opportunities, threats, risks, strategic developments, product advancements, and other key features. The report covers market size estimation, share, growth rate, global position, and regional analysis of the market. The report also covers forecast estimations for investments in the Testosterone Replacement Therapy industry from 2020 to 2027.

The report is furnished with the latest market dynamics and economic scenario in regards to the COVID-19 pandemic. The pandemic has brought about drastic changes in the economy of the world and has affected several key segments and growth opportunities. The report provides an in-depth impact analysis of the pandemic on the market to better understand the latest changes in the market and gain a futuristic outlook on a post-COVID-19 scenario.

Get a sample of the report @ https://reportsglobe.com/download-sample/?rid=75349

The report provides an in-depth analysis of the key developments and innovations of the market, such as research and development advancements, product launches, mergers & acquisitions, joint ventures, partnerships, government deals, and collaborations. The report provides a comprehensive overview of the regional growth of each market player.

Additionally, the report provides details about the revenue estimation, financial standings, capacity, import/export, supply and demand ratio, production and consumption trends, CAGR, market share, market growth dynamics, and market segmentation analysis.

The report covers extensive analysis of the key market players in the market, along with their business overview, expansion plans, and strategies. The key players studied in the report include:

Furthermore, the report utilizes advanced analytical tools such as SWOT analysis and Porters Five Forces Analysis to analyze key industry players and their market scope. The report also provides feasibility analysis and investment return analysis. It also provides strategic recommendations to formulate investment strategies and provides insights for new entrants.

Request a discount on the report @ https://reportsglobe.com/ask-for-discount/?rid=75349

The report is designed with an aim to assist the reader in taking beneficial data and making fruitful decisions to accelerate their businesses. The report provides an examination of the economic scenario, along with benefits, limitations, supply, production, demands, and development rate of the market.

Testosterone Replacement Therapy Market Segmentation, By Type

Testosterone Replacement Therapy Market Segmentation, By Applications

Request customization of the report @https://reportsglobe.com/need-customization/?rid=75349

Regional Analysis of the Market:

For a better understanding of the global Testosterone Replacement Therapy market dynamics, a regional analysis of the market across key geographical areas is offered in the report. The market is spread acrossNorth America, Europe, Latin America, Asia-Pacific, and Middle East & Africa.Each region is analyzed on the basis of the market scenario in the major countries of the regions to provide a deeper understanding of the market.

Benefits of the Global Testosterone Replacement Therapy Report:

To learn more about the report, visit @ https://reportsglobe.com/product/global-covid-19-impacttestosterone-replacement-therapy-sales-market/

Thank you for reading our report. To learn more about report details or for customization information, please contact us. Our team will ensure that the report is customized according to your requirements.

How Reports Globe is different than other Market Research Providers

The inception of Reports Globe has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.

Our team at Reports Globe follows a rigorous process of data validation, which allows us to publish reports from publishers with minimum or no deviations. Reports Globe collects, segregates, and publishes more than 500 reports annually that cater to products and services across numerous domains.

Contact us:

Mr. Mark Willams

Account Manager

US: +1-970-672-0390

Email:[emailprotected]

Web:reportsglobe.com

See original here:
Testosterone Replacement Therapy Market to Witness Exponential Growth by 2020-2027 | Leading Players AbbVie, Endo International, Eli lilly, Pfizer,...


Page 517«..1020..516517518519..530540..»